Responses
Poster Presentations
Rheumatoid arthritis - anti-TNF therapy
SAT0174 Use of a 8-week observational period for predicting remission and low disease activity at 52 weeks in ra patients treated with certolizumab pegol – a multicenter study
Compose a Response to This Article
Other responses
No responses have been published for this article.